SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Clinicom Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
#187262108
(CUSIP Number)
Check the following box if a fee is being paid with this statement.
(A fee is not required only if the filing person: (1) has a
previous statement on file reporting beneficial ownership of more
than five percent of the class of securities described in Item 1;
and (2) has filed no amendment subsequent thereto reporting
beneficial ownership of five percent or less of such class.) (See
Rule 13d-7.)
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided
in a prior cover page.
The information required in the remainder of this cover page shall
not be deemed to be "filed" for the purpose of Section 18 of the
Securities Exchange Act of 1934 ("Act") or otherwise subject to
the liabilities of that section of the Act but shall be subject to
all other provisions of the Act (however, see the Notes).
(Continued on following pages(s))
Page 1 of 5 Pages
CUSIP No. 187262108 Page 2 of 5 Pages
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Dean Witter Health Sciences Trust
IRS No. 13-3674250
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) (b)
Not Applicable. Not Applicable.
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Massachusetts
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
5 SOLE VOTING POWER
-0- shares of common stock
6 SHARED VOTING POWER
7 SOLE DISPOSITIVE POWER
-0-
8 SHARED DISPOSITIVE POWER
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
-0-
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.00
12 TYPE OF REPORTING PERSON*
IV
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
Schedule 13G
Issuer: Clinicom Inc.
CUSIP NO.:187262108
Item 1(a) Name of Issuer:
Clinicom Inc.
Item 1(b) Address of Issuer's Principal Executive Offices:
4720 Walnut Street
Boulder, Colorado 80301
Item 2(a) Name of Person Filing:
Dean Witter Health Sciences Trust
Item 2(b) Address of Principal Business Office:
Two World Trade Center, New York, NY 10048
Item 2(c) Citizenship:
Massachusetts
Item 2(d) Title of Class Securities:
Common Stock
Item 2(e) CUSIP Number:
187262108
Item 3 If this statement is filed pursuant to Rules 13d -
1(b), or 13d-2(b), check whether the person filing
is a:.
(a) ( ) Broker or Dealer registered under Section 15 of the
Act.
(b) ( ) Bank as defined in Section 3(a) (6) of the Act.
(c) ( ) Insurance Company as defined in Section 3(a) (19) of
the Act.
(d) (x) Investment Company registered under Section 8 of the
Investment Company Act.
Page 3 of 5 Pages
send/sch.13G.6<PAGE>
Item 4 Ownership:
(a) Amount of Beneficially Owned:
-0-
(b) Percent of Class:
0.00
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the
vote -0-
(ii) shared power to vote or to direct the
vote -0-
(iii) sole power to dispose or to direct
the disposition of -0-
(iv) shared power to dispose or to direct
the disposition of -0-
Item 5 Ownership of Five Percent or Less of a Class.
Not Applicable.
Item 6 Ownership of More than Five Percent on Behalf of
Another Person.
Not Applicable.
Item 7 Identification and Classification of the
Subsidiary Which Acquired the Security Being
Reported on By the Parent Holding Company.
Not Applicable.
Item 8 Identification and Classification of Members of
the Group.
Not Applicable.
Item 9 Notice of Dissolution of Group.
Not Applicable.
Page 4 of 5 Pages
send/sch.13G.6
Item 10 Certification.
By signing below I certify that, to the best
of my knowledge and belief, the securities
referred to above were acquired in the ordinary
course of business and were not acquired for the
purpose of and do not have the effect of
changing or influencing the control of the issuer
of such securities and were not acquired in
connection with or as a participant in any
transaction having such purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the
information set forth in this statement is true,
complete and correct.
February 14, 1995
(Date)
/s/Ronald Worobel/Vice President
(Signature)
Ronald Worobel/Vice President
(Name/Title)
Page 5 of 5 Pages
send/sch13G.6
